|
|
Volumn 97, Issue 24, 2005, Pages 1804-1805
|
|
Consumer groups look to improve adverse event reporting systems
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
PAMIDRONIC ACID;
ROFECOXIB;
ROTAVIRUS VACCINE;
ZOLEDRONIC ACID;
BONE DISEASE;
BONE MALFORMATION;
BONE NECROSIS;
BREAST CANCER;
CANCER SURVIVAL;
COUGHING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
HEART INFARCTION;
HUMAN;
INTESTINE OBSTRUCTION;
JAW DISEASE;
MULTIPLE MYELOMA;
NOTE;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK FACTOR;
STROKE;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANTINEOPLASTIC AGENTS;
BONE DENSITY CONSERVATION AGENTS;
CONSUMER SATISFACTION;
DIPHOSPHONATES;
DRUG APPROVAL;
HUMANS;
IMIDAZOLES;
MULTIPLE MYELOMA;
OSTEONECROSIS;
PRODUCT SURVEILLANCE, POSTMARKETING;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 29844445609
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/dji458 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|